Physician profile
Aaron C Earles
NPI 1740502095
$8,388.34
in general payments reported to CMS, 2019-2025
37 companies · $829 in 2025
The $829 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $598 · 2021: $835 · 2022: $1,516 · 2023: $1,534 · 2024: $2,565 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,877 · Travel and Lodging: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,876.55 |
| Travel and Lodging | $1,051.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,691.34 | 2022-2025 | Indigo System, Smart Coil, Penumbra System |
| Abiomed | $835.14 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $736.62 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $655.43 | 2019-2025 | Farxiga, Wainua |
| Boston Scientific Corporation | $487.39 | 2019-2025 | Rotablator Rotational Atherectomy System Console Kit, Watchman Flx, Enroute Transcarotid Stent |
| Amgen INC. | $381.03 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $371.40 | 2021-2025 | Verquvo |
| Cvrx, INC. | $356.70 | 2023-2024 | Barostim Neo System |
| Biotronik INC. | $317.39 | 2019-2025 | Biomonitor, Orsiro Mission, Amvia Edge |
| Janssen Pharmaceuticals, INC | $287.76 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $212.03 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.60 | 2020-2024 | Jardiance |
| Abbott Laboratories | $196.52 | 2021-2022 | |
| Pfizer INC. | $178.79 | 2021-2025 | |
| Daiichi Sankyo INC. | $177.82 | 2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $135.05 | 2020-2022 | |
| Cook Medical LLC | $129.91 | 2023-2025 | Zilver Ptx, Icast Covered Stent System, 6mmx22mmx120cm |
| Medtronic, INC. | $106.40 | 2024-2025 | Onyx Frontier, Hawkone |
| Lexicon Pharmaceuticals, INC. | $104.83 | 2023-2024 | Inpefa |
| Bard Peripheral Vascular, INC. | $102.98 | 2021 | |
| Avinger INC. | $97.79 | 2022 | |
| Philips North America LLC | $95.48 | 2020-2022 | |
| Amarin Pharma, INC. | $79.30 | 2020-2021 | |
| Daxor Corporation | $61.41 | 2023 | Bva-100 |
| Kowa Pharmaceuticals America, INC. | $56.31 | 2019-2021 | |
| Bardy Diagnostics, INC. | $45.00 | 2022 | |
| Baxter Healthcare | $42.04 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Ge Healthcare | $37.21 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $34.47 | 2019-2023 | Evkeeza |
| Edwards Lifesciences Corporation | $29.82 | 2022 | |
| Medtronic Vascular, INC. | $25.65 | 2019 | |
| Cardiva Medical, INC. | $23.54 | 2019 | |
| Irhythm Technologies, INC. | $20.76 | 2022 | |
| Glaxosmithkline, LLC. | $18.93 | 2025 | Arexvy, Shingrix |
| Novo Nordisk INC | $18.92 | 2023 | Ozempic |
| E.R. Squibb & Sons, L.L.C. | $17.82 | 2023 | Eliquis |
| Terumo Medical Corporation | $14.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Earles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.